Our study could shed light on the potential pathway where EA exerts effects on the mechanism of EA treatment for obesity through the hypothalamic Tsc1 promoter demethylation and inhibition of the activity of mTORC1 signaling pathway. This evidence concerns the gene TSC1 and obesity due to melanocortin 4 receptor deficiency.